Endnu en tilføjelse til kalenderen:
-
Endnu en tilføjelse til kalenderen:
Zanolimumab (HuMax CD4) i Mycosis Fungoides (CTCL) fase III:Estimated Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Det har vel også lidt indflydelse på Genmab, hvis der kommer positive resultater fra TenX Biopharma.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind